Joyn Bio Stock
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Sign up today and learn more about Joyn Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Joyn Bio Stock
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
Forbes - May, 31 2019This Company's GMOs Will Help Feed The World, Without Ever Being Eaten
Genetic Literacy Project - Jun, 5 2018Can Joyn Bio's genetically engineered microbes replace chemical fertilizers?
agprofessional.com - Mar, 21 2018Partnership Joyn Bio to Reduce Negative Impact of Nitrogen Fertilizer
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase